𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Thirty-one-year survival following chemotherapy and autologous bone marrow in malignant lymphoma

✍ Scribed by Haurani, Farid I.


Book ID
101214369
Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
33 KB
Volume
55
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

✦ Synopsis


A 21-year-old woman with malignant lymphoma received a large dose of nitrogen mustard followed by autologous bone marrow. She achieved a complete remission that lasted 21 years. This was followed in a span of 10 years by two relapses that responded to chemotherapy and splenectomy. Death resulted from sepsis. At autopsy, there was minimal evidence of malignant lymphoma, but evidence for side effects of chemotherapy was present. Am.


πŸ“œ SIMILAR VOLUMES


IMVP-16 followed by high dose chemothera
✍ P. C. Huijgens; G. J. Ossenkoppele; J. Van Der Lelie; L. L. M. Thomas; M. J. Wij πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 413 KB

Thirty patients with high-grade malignant lymphoma were treated with ifosfamide-VP16213-methotrexate (IMVP-16) combination chemotherapy after failing to respond completely or after relapsing on CHOP-like therapy. Responders to the salvage therapy subsequently were treated with ablative chemotherapy

Quality of life in patients surviving at
✍ Eric P. Winer; Celeste Lindley; Melanee Hardee; William T. Sawyer; Caryn Brunatt πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 73 KB πŸ‘ 2 views

## Background: Over the past decade, high dose chemotherapy with autologous bone marrow (hdc-abmt) support has been used increasingly in the treatment of patients with breast cancer. in evaluating the results of hdc-abmt in patients with breast cancer, an assessment of quality of life can add to th

Physical exercise and quality of life in
✍ Kerry S. Courneya; Melanie R. Keats; A. Robert Turner πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 2 views

Preliminary evidence indicates that physical exercise may be an effective strategy for the rehabilitation of cancer patients following high dose chemotherapy (HDC) and bone marrow transplantation (BMT), but the focus of this research has been on physical fitness and medical outcomes. In the present